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ellular pathways relay information through dy-
namic protein interactions. We have assessed the
kinetic properties of the murine double minute
protein (MDM2) and von Hippel-Lindau (VHL) ubiquitin
ligases in living cells under physiological conditions that
alter the stability of their respective p53 and hypoxia-
inducible factor substrates. Photobleaching experiments
reveal that MDM2 and VHL are highly mobile proteins in
settings where their substrates are efﬁciently degraded.
The nucleolar architecture converts MDM2 and VHL to a
static state in response to regulatory cues that are associ-
C
 
ated with substrate stability. After signal termination, the
nucleolus is able to rapidly release these proteins from
static detention, thereby restoring their high mobility pro-
ﬁles. A protein surface region of VHL’s 
 
 
 
-sheet domain
was identiﬁed as a discrete [H
 
 
 
]-responsive nucleolar
detention signal that targets the VHL/Cullin-2 ubiquitin li-
gase complex to nucleoli in response to physiological
fluctuations in environmental pH. Data shown here pro-
vide the ﬁrst evidence that cells have evolved a mechanism
to regulate molecular networks by reversibly switching
proteins between a mobile and static state.
 
Introduction
 
Conjugation of ubiquitin (ubiquitylation) to proteins destines
them for very different fates in the cell (Weissman, 2001; Mura-
tani and Tansey, 2003; Ciechanover, 2005). Although targeting
proteins for degradation via the 26S proteasome is the best-stud-
ied role of ubiquitylation, this modification is integral to several
biochemical pathways including receptor internalization (Ter-
rell et al., 1998), chromatin maintenance (Muratani and Tansey,
2003) and DNA repair (Russell et al., 1999; Gillette et al.,
2001). The ubiquitin system is sustained by the interaction of
multiple dynamic molecular networks that begin with the load-
ing of ubiquitin onto an ubiquitin-activating enzyme (E1). The
ubiquitin moiety is then transferred to a ubiquitin-conjugating
enzyme (E2), and finally, a ubiquitin protein ligase (E3) cataly-
ses the transfer of ubiquitin from E2 to the lysine residue of a
specific substrate, thereby altering its cellular fate.
There are many more E3s in the cell than there are E1s
and E2s combined, and it is thought that E3s determine the
specificity of substrate recognition within the ubiquitin system.
The function of a ubiquitin ligase can be regulated by control-
ling the ligase or its substrate at various levels such as post-
translational modifications, interactions with regulatory factors,
or subcellular localization (Petroski and Deshaies, 2005).
The complexity of E3 regulatory mechanisms is well
demonstrated by the mechanisms controlling the degradation
of the p53 tumor suppressor protein (Michael and Oren,
2003). The murine double minute protein MDM2 ubiquitin
ligase targets p53 for ubiquitylation in the nucleus followed
by nuclear export and degradation by cytoplasmic 26S pro-
teasome (Momand et al., 1992; Oliner et al., 1993; Freedman
and Levine, 1998; Roth et al., 1998). Various signals can al-
ter the function of MDM2 within this setting. DNA damage
rapidly activates the ataxia telangiectasia mutated protein,
which phosphorylates MDM2 to prevent the ubiquitylation
of p53 (Appella and Anderson, 2001). Replicative senes-
cence induces the tumor suppressor ARF to bind MDM2 and
inactivate it by both immediately reducing its ability to rec-
ognize p53 in the nucleoplasm (Llanos et al., 2001) and
translocating MDM2 to the nucleolus (Tao and Levine, 1999;
Weber et al., 1999), a major nuclear compartment (Carmo-
Fonseca et al., 2000). Similarly, perturbations to ribosomal
biogenesis induce the ribosomal protein L11 to bind MDM2
and inhibit its function by relocating it to the nucleolus (Loh-
rum et al., 2003).
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Functional regulation of E3s by the nucleolus has also
been observed in the von Hippel-Lindau (VHL) tumor suppres-
sor/hypoxia-inducible factor (HIF) system (for review see Kae-
lin, 2002; Mekhail et al., 2004a). HIF activates an array of
genes that mediate cellular response to low oxygen availability
(Semenza, 2000). In the presence of oxygen, the 
 
 
 
 subunit
of HIF (HIF
 
 
 
) is post-translationally modified by enzymes
known as prolyl hydroxylases (PHDs). This allows the VHL
tumor suppressor, the particle recognition motif of an elongin
C/Cullin-2 ubiquitin ligase, to recognize HIF
 
 
 
 and target it for
nuclear ubiquitylation. VHL-mediated shuttling of HIF
 
 
 
 to the
cytoplasm then results in its destruction by the 26S proteasome
(Lee et al., 1999; Groulx and Lee, 2002) in a manner reminis-
cent of the MDM2/p53 system. Several physiological cues can
modulate the function of VHL within this setting. PHDs re-
quire molecular oxygen and hypoxia prevents hydroxylation of
HIF, allowing it to evade recognition by VHL and degradation.
In addition, we previously reported that a decrease in environ-
mental pH triggers the relocation of VHL to the nucleolus, neu-
tralizing its ability to degrade nuclear HIF even in the presence
of oxygen (Mekhail et al., 2004a,b).
The nucleolus has traditionally been viewed as a factory
for the production of ribosomes (Lam et al., 2005). More re-
cently, this nuclear compartment has been linked to numerous
cellular activities including cell cycle control (Shou et al.,
1999, 2001; Visintin et al., 1999; Azzam et al., 2004), DNA
damage repair (van den Boom et al., 2004), and tRNA process-
ing (Paushkin et al., 2004). Although the nucleolus has a dis-
tinct set of “resident” proteins, it is now clear that these pro-
teins are in continuous flux between the nucleolus and other
cellular compartments (Dundr et al., 2000, 2002; Phair and
Misteli, 2000; Chen and Huang, 2001; Misteli, 2001; Carmo-
Fonseca, 2002; Andersen et al., 2005; Tsai and McKay, 2005).
This dynamic nature is facilitated by a fundamental character-
istic of nuclear compartments; that is the lack of a delineating
membrane. For example, thousands of molecules of the rRNA
processing factor fibrillarin (FIB), which displays steady-state
nucleolar localization, exit the nucleolus each second (Phair
and Misteli, 2000). The highly dynamic properties of proteins
in the nucleus follow a stochastic model of high molecular mo-
bility to ensure efficient functional interactions (Misteli, 2001).
An advantage of such probabilistic movement is the ability to
achieve rapid responses to signaling cues. For example, a slight
increase in the quantity of a modified protein results in a rela-
tively high probability of encountering its target. As mentioned
above, resident nucleolar proteins are dynamic molecules that
can functionally engage in subcellular trafficking between the
nucleolus and other cellular compartments. Therefore, it re-
mains unclear how the highly dynamic nucleolus inactivates
the function of E3 enzymes, as these macromolecules would be
predicted to retain their dynamic nature and maintain func-
tional molecular interactions.
Here, we report the unexpected observation that the nu-
cleolar architecture is able to reversibly capture and alter the
dynamic properties of ubiquitin ligases. We show that VHL
and MDM2 are highly mobile proteins that can be statically de-
tained by the nucleolus to prevent functionally required molec-
Figure 1. pH-dependent kinetics of VHL subcellular trafficking. (A) C2C12-
differentiated myotubes were cultured in standard (SD) media and infected
to express adenovirus-introduced VHL-GFP. Cells were replenished with
either fresh SD media (pH 7.2) or different AP media (initial pH 7.2) that
allow maximal extracellular acidification to pH 6.9, 6.6, 6.4, 6.2, or 6.0
(see Materials and methods). Cells were transferred to hypoxia (1% O2)
for 18 h. VHL redistributed to nucleoli only in conditions of pH 6.4 or
lower (images of pH 6.2 and 6.0 are not depicted). Extracellular pH is in-
dicated on each panel. Insets show Hoechst staining of DNA. Bars (A, B,
and E), 10  m. (B) After localization of VHL-GFP to the nucleolus, myo-
tubes were replenished with AP media previously maximally acidified to
indicated pH levels, or with fresh SD media. VHL reverted to nucleo-cyto-
plasmic distribution only when the pH of the media was higher than 6.4.
(C) Different cell types were treated as in A and B to identify the pH thresh-
olds required for nucleolar targeting of VHL (n   40 for each tested pH
value). (D) Kinetics of VHL nucleolar localization in acidosis and release
after neutralization in differentiated myotubes. Cells were exposed to dif-
ferent AP media as in A to induce VHL nucleolar redistribution, and all me-
dia were neutralized to pH 7.2 by addition of NaOH (arrow). Time zero
indicates time at which the pH of AP media reached 6.4. For the 6.5 and
6.7 sets, time zero is matched to that of the pH 6.4 set. (E) Cells were in-
cubated in AP media (initial pH 7.2) that blocks acidification beyond pH
6.0. After reaching the acidification level matching the pH threshold re-
quired to trigger nucleolar targeting of any given cell-type (time zero), the
localization of VHL-GFP was monitored over time. Upon reaching the pH
threshold, VHL shifts from mainly cytoplasmic to mainly nucleoplasmic
before triggering nucleolar localization. 
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ular interactions in response to physiological cues. Based on
these data, we suggest that cells have evolved a mechanism to
regulate the function of proteins by reversibly switching them
between mobile and static states.
 
Results
 
[H
 
 
 
]-regulated kinetics of VHL 
subcellular trafficking
 
Ischemic tissues or hypoxic cells normally acidify their extra-
cellular milieu as a physiological consequence of anaerobic
glycolysis. This is best exemplified by muscle fatigue, in which
myotubes produce lactic acid after exposure to hypoxia. Study
of the ubiquitin ligase component VHL within this setting re-
vealed its functional regulation by changes in environmental
H
 
 
 
 concentrations (Mekhail et al., 2004a). VHL engages in nu-
clear/cytoplasmic trafficking in neutral conditions but accumu-
lates in the nucleolus upon a decrease in extracellular pH, a
process that results in stabilization of its substrate HIF. Differ-
entiated myotubes can be incubated in standard (SD) media,
which prevents fluctuations in pH, or in acidification-permissive
(AP) media, which is prepared to enable hypoxic cells to acid-
ify their extracellular milieu to varying degrees (see Materials
and methods) (Mekhail et al., 2004a). VHL-GFP is observed in
its typical diffuse nuclear cytoplasmic distribution under neu-
tral pH conditions, independent of oxygen tension (Fig. 1 A,
left; Mekhail et al., 2004a). A rapid redistribution of VHL-GFP
to nucleoli was observed only when hypoxic myotubes were
incubated in AP media that allow the myotubes to acidify their
environment to pH 6.40 or lower (Fig. 1, A and D; see Fig.
S1, A and B, for cell viability controls, available at http://
www.jcb.org/cgi/content/full/jcb.200506030/DC1), indicating
the existence of a pH threshold required for triggering nucle-
olar localization of VHL. The threshold displayed cell type–
specific differences within the 6.60–5.80 pH range (Fig. 1 C;
Fig. S2). VHL efficiently reverted to a diffuse nuclear-cyto-
plasmic localization under hypoxic conditions only when cells
were replenished with media at values higher than the pH
threshold required to trigger nucleolar localization (Fig. 1, B–D).
Closer examination of this system reveals that the relocation of
VHL to the nucleolus is a two-step process, where the protein
displays an initial shift from mainly cytoplasmic to mainly nu-
cleoplasmic localization before initiating any detectable target-
ing to the nucleolus, in all tested cell lines (Fig. 1 E; Fig. S1, C
and D). These data suggest that the subcellular trafficking dy-
namics of VHL are regulated by a multilayered cellular mecha-
nism that gauges environmental hydrogen ion concentrations.
 
Different kinetics of nucleolar VHL and 
resident nucleolar proteins after 
transcriptional inhibition
 
Due to the role of the nucleolus in ribosomal biogenesis, per-
turbations to transcription, such as by treatment with low levels
of actinomycin D (ActD), alter the trafficking properties of
steady-state nucleolar proteins between the nucleolus and
the nucleoplasm (Chen and Huang, 2001; Andersen et al.,
2005). For example, the human immunodeficiency virus (HIV)
mRNA exporter REV is a dynamic nucleolar protein that redis-
tributes to the nucleoplasm and cytoplasm after transcriptional
inhibition under both neutral (unpublished data; Stauber et al.,
1995; Daelemans et al., 2005) and acidic (Fig. 2 A; Fig. 2 B,
top) conditions. In contrast, the nucleolar localization of VHL
in acidosis persisted in the absence of transcription (Fig. 2 B,
bottom). Similar results were obtained in experiments using
VHL-BFP and REV-GFP (unpublished data). The ability of
REV to rapidly alter its steady-state distribution under these
conditions is greatly enhanced by its strong nuclear export se-
quence (NES). We therefore tested whether fusion of this NES
Figure 2. Kinetics of nucleolar VHL and REV. (A and B)
MCF7 cells cotransfected to express VHL-GFP and REV-BFP
were incubated in hypoxia in SD or AP conditions. After lo-
calization of VHL-GFP to the nucleolus, cells were either fixed
and immunostained for nucleolar B23 (A) or treated with 10
 g/ml ActD and monitored over time (B). Arrows in A indi-
cate the same position in the cell and dashed cellular outlines
are shown in B. Insets in B show a time-matched set that was
not treated with ActD. (C and D) VHL-GFP-NES fusion protein
is not released from nucleoli after ActD treatment. MCF7 cells
were transfected to express VHL-GFP, VHL-GFP-NES, or GFP-
NES alone and transferred to hypoxia in SD or AP media.
Shown are images 50 min after AP media reached the pH
6.5 threshold. Where indicated, leptomycin B (LMB) was
added when AP media reached pH 6.65 (usually 30–40
min) before pH 6.5 time point. Insets in C show Hoechst
staining of DNA. (D) Ratiometric fluorescence measurements
of hypoxic-acidotic cells initially displaying nucleolar REV-
BFP, VHL-GFP, and VHL-GFP-NES after ActD treatment. 
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to VHL would enable it to release from nucleoli of acidotic
cells after transcriptional inhibition. VHL-GFP-NES fusion
localized almost exclusively to the cytoplasm under neutral
conditions but was restricted to nucleoli at steady-state under
acidosis (Fig. 2 C). ActD treatment failed to release the VHL-
GFP-NES fusion protein from nucleoli (Fig. 2, C and D),
suggesting that the subcellular trafficking dynamics of VHL
in the nucleolus significantly differ from the dynamics of res-
ident nucleolar proteins.
 
Physiological regulation of VHL ubiquitin 
ligase dynamics by the nucleolus
 
We therefore used FRAP to assess how the nucleolus affects
the dynamic properties of GFP-tagged VHL in living cells
(Lippincott-Schwartz et al., 2003). Specific cellular regions ex-
pressing fusion proteins were bleached with the use of a laser
pulse that irreversibly quenches the GFP signal, and the recov-
ery of signal in the bleached area was recorded by time-lapse
confocal microscopy. The kinetics and extent of recovery of
fluorescence in a cellular region after bleaching are reflective
of the dynamics of the studied fluorescent chimeras.
Cells cultured under standard neutral conditions dis-
played an essentially complete recovery of VHL-GFP fluores-
cence within seconds of bleaching nucleoplasmic (Fig. 3, A
and G) or cytoplasmic (see Fig. 7 D) regions. We first assessed
the capacity of the nucleolus to sustain dynamic shuttling under
acidosis by monitoring resident nucleolar proteins, such as the
rRNA-processing factors fibrillarin (FIB) and nucleophosmin
(NPM or B23), as well as the RNA polymerase I preinitation
factor upstream binding factor 1 (UBF1). Acidosis did not alter
the steady-state distribution of any of the studied resident nu-
cleolar proteins (Fig. 3, D and E) compared with neutral condi-
tions. In addition, these proteins displayed a rapid pH-inde-
pendent recovery of fluorescence after bleaching of a single
nucleolus within cells with multiple nucleoli (Fig. 3, C and F),
indicating dynamic protein shuttling between nucleoli of aci-
dotic cells. In contrast, nucleolar VHL failed to display recovery
of fluorescence under the same culture and bleaching parame-
ters (Fig. 3, B and G), suggesting that acidosis alters the mobil-
ity profile of VHL. Similar to previous reports, reduction of the
temperature from 37 to 22
 
 
 
C did not have any significant effect
on the kinetics or extent of recovery of any of the tested pro-
teins in the nucleus or cytoplasm (unpublished data; see Phair
and Misteli, 2000). These data suggest that the redistribution of
VHL to the nucleolus in response to increases in extracellular
hydrogen ion concentrations may alter its general dynamic
characteristics in the cell.
The dynamics of VHL were next analyzed by fluores-
cence loss in photobleaching (FLIP) experiments (Lippincott-
Schwartz et al., 2003). In FLIP, a living cell is repeatedly hit
with a laser beam in the same region. Loss of fluorescence in
an area outside the bleached spot is reflective of protein mobil-
ity between that area and the bleached spot. A rapid loss of
VHL-GFP fluorescence was observed in essentially the whole
nucleus after repetitive bleaching of a small nucleoplasmic re-
gion in cells incubated under neutral conditions (Fig. 4 A).
Studies presented further in this report (Fig. S3, available at
http://www.jcb.org/cgi/content/full/jcb.200506030/DC1) will
study the nuclear-cytoplasmic trafficking properties of VHL.
These observations indicate that VHL participates in dynamic
molecular networks.
Next, cells were transfected to express low levels of
VHL-GFP to allow for a complete redistribution of the protein
chimera to the nucleolus after acidification in hypoxia (Fig. 4 B,
first panel; see Mekhail et al., 2004a). Under these conditions,
VHL-GFP fluorescence in the nucleolus was unaffected by re-
petitive bleaching of a nucleoplasmic (Fig. 4, B and F) or cyto-
plasmic (unpublished data) region. In stark contrast, resident
nucleolar proteins rapidly dissociate from the nucleolus in hy-
poxic-acidotic cells (Fig. 4, C and F). We next examined
whether interaction with the nucleolar architecture is required
for acidosis-mediated modification of VHL dynamics. Cells
were thus transfected to express higher levels of VHL-GFP,
saturating nucleolar binding sites and preventing the full redis-
tribution of the fluorescent protein chimera to the nucleolus
Figure 3. FRAP analysis reveals that VHL does not shuttle between nucleoli
in acidosis. MCF7 cells transiently transfected to express low levels of VHL-
GFP, B23-GFP, FIB-GFP, or UBF1-GFP were incubated in hypoxia under
SD or AP conditions. (A–C) Cells were imaged before and after bleaching
of indicated nucleoplasmic regions (dashed square) or specific nucleoli
(arrows) within nuclei (dashed circles). Post-bleach time is indicated in sec-
onds. Areas of interest are shown as pseudocolored panels to better illus-
trate minimal changes in fluorescence. (D and E) Steady-state localization
of GFP-tagged proteins after incubation in SD or AP media under hypoxia.
(F and G) Quantitation of recovery kinetics. Fluorescence intensity in the
bleached region was measured and expressed as relative recovery (see
Materials and methods). For quantitation, at least 10 cells were analyzed
for each result. 
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after acidification in hypoxia (Fig. 4 D, first panel). This estab-
lishes two different protein pools in the cell—nucleoplasmic
and nucleolar. Although repetitive bleaching of a nuclear re-
gion in these cells resulted in complete loss of nucleoplasmic
fluorescence, nucleolar VHL-GFP signal remained constant
over the course of the experiment (Fig. 4, D, E, and G). No sig-
nificant bleaching was observed in neighboring nuclei in all of
the experiments. Similar to nuclear VHL-GFP under neutral
conditions, the nucleoplasmic pool of VHL-GFP in acidosis
was able to engage in nuclear export as revealed by inverse
FRAP (iFRAP) analysis of living cells (Lippincott-Schwartz et
al., 2003), thereby indicating that this nucleoplasmic pool re-
tains functional interactions with the nucleopore architecture in
acidosis (Fig. S3). These data indicate that the interaction of
VHL with the nucleolar architecture is required for acidosis-
mediated modification of VHL protein dynamics.
We next studied VHL dynamics using polykaryon fusion
assays, which provide an alternative approach to photobleach-
ing in assessing changes in subcellular trafficking of proteins
(Walther et al., 2003). Cells expressing VHL-GFP were fused in
a standard polyethylene glycol (PEG) fusion assay. VHL re-
mains nuclear-cytoplasmic in polykaryonic cells (Fig. 5 A, a and
b; Lee et al., 1999). Transfer to hypoxia resulted in acidification
of the media and VHL-GFP displayed its typical two-step local-
ization process to the nucleolus (Fig. 5 A, c–g). It is important to
note that nucleolar VHL signal was equally distributed between
the nuclei of a polykaryonic cell (Fig. 5 A), indicating that VHL-
GFP displays no preference for the nucleoli of one nucleus over
another. Next, we cocultured VHL-GFP–expressing and nonex-
pressing cells under standard conditions, then transferred them to
hypoxia in AP media. After the redistribution of VHL-GFP to
nucleoli, cells were rapidly fused and replenished with their own
acidified AP media. This process yielded a significant number of
polykaryonic cells where the fluorescence observed in the cell is
only associated with nucleoli of only one or two nuclei, whereas
other nuclei displayed no fluorescence (Fig. 5 B). VHL-GFP
failed to exhibit any change in localization up to 3 h after fusion.
In contrast, under the same conditions B23-GFP (Fig. 5 C) and
REV-GFP (unpublished data) redistributed from the nucleoli of a
single cell to the nucleo-cytoplasm and nucleoli of the acceptor
Figure 4. FLIP analysis reveals that nucleolar VHL does not
traffic between the nucleolus and nucleoplasm in acidosis.
MCF7 cells transiently transfected to express low (A–C, and
F) or high (D, E, and G) levels of VHL-GFP or B23-GFP were
incubated in hypoxia under SD or AP conditions. At time
points matching the relocation of VHL-GFP (low levels set) to
nucleoli, all cells were submitted to a FLIP analysis where nu-
cleoplasmic regions (white squares) within specific nuclei
(dashed circles) were repeatedly bleached. Cells were im-
aged between pulses. (F and G) Corresponding kinetics of
loss of fluorescence. 
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(nontransfected) cells of polykaryons. In addition to bleaching
experiments, results from the fusion assays reveal a role for the
nucleolus in regulating the subcellular dynamic profile of the
VHL tumor suppressor.
 
Static detention of MDM2 and VHL 
ubiquitin ligase by the nucleolus
 
MDM2 displays a diffuse nuclear localization under standard
culture conditions. FRAP and FLIP experiments revealed that
MDM2 is a highly dynamic protein within this setting (Fig. 6
A; Fig. S4 A, available at http://www.jcb.org/cgi/content/full/
jcb.200506030/DC1). MDM2 localizes to the nucleolus in re-
sponse to perturbations in ribosomal biogenesis after treatment
with low levels of ActD that inhibit RNA polymerase I (Fig. 6 B;
Fig. S4 B; Lohrum et al., 2003). MDM2 is unable to target p53
for degradation under these conditions. We therefore assessed
the dynamics of MDM2 after relocation to the nucleolus. When
nucleolar, the dynamic profile of MDM2 significantly changed
as GFP fluorescence did not exhibit any recovery/redistribution
in FRAP experiments after bleaching of the nucleolus (Fig. 6 B)
or loss in FLIP experiments after repetitive bleaching of a nucle-
oplasmic (Fig. S4 B) or cytoplasmic (unpublished data) region.
Similar to VHL (Fig. 4, D and G), the interaction of MDM2 with
the nucleolar architecture is required for modification of its traf-
ficking dynamics as evidenced by the quick recovery of MDM2
in the nucleoplasm of transcriptionally inhibited cells expressing
high levels of the protein in FRAP (Fig. 7 A). We next evaluated
the dynamics of VHL and MDM2 ligases within the nucleolar
space. VHL and MDM2 did not exhibit any fluorescence recov-
ery after bleaching of an area within the nucleolus (Fig. 7, A and
C). In contrast, B23 remained localized to nucleoli at steady-
state within our experimental settings (SD, AP, and RS), retain-
ing its highly mobile properties, though prolonged incubation
with ActD resulted in B23 accumulating in the nucleoplasm
(Fig. 7 B; unpublished data). Upon photobleaching, a border is
created between the bleached area and the gradient of concentra-
tion established by the remaining fluorescent molecules (Fig.
7 C). For moving proteins, this border changes its shape as well
as its position within the field of vision over time. Statically de-
tained cellular components do not exhibit significant changes in
these variables. We therefore compared the characteristics of
borders of concentration gradients established by bleaching fluo-
rescently labeled proteins when localized to different regions of
the cell. Although analysis of concentration gradient borders in
the nucleoplasm and cytoplasm revealed a highly dynamic pro-
file of protein mobility, borders established within the nucleolar
space neither changed in shape nor moved within the field of vi-
sion for up to 2 h after bleaching (Fig. 7, C–F; unpublished data).
A similar static protein profile was observed for MDM2 in the
nucleolus (unpublished data). These findings suggest that VHL
and MDM2 are targeted for static detention in the nucleolus in
response to physiological cues.
Figure 5. Long-term detention of VHL within the nucleolar space revealed
by the inability of VHL to release from nucleoli in a polykaryon fusion assay.
(A) MCF7 cells transiently expressing VHL-GFP were fused in a standard
PEG fusion assay and incubated in SD media for 30 min (b). Inset shows
Hoechst staining of DNA. Cells were replenished with AP media and
transferred to hypoxia. VHL-GFP localization was monitored after reach-
ing the pH 6.5 threshold (c–g). Nuclei within a polykaryonic cell were al-
ways synchronized in the rates of nucleolar appearance of VHL-GFP. This
is not necessarily the case for monokaryonic cells in close proximity under
AP conditions (h). (B) Unaltered MCF7 cells were cocultured under stan-
dard conditions with either MCF7 (homokaryon assay) or NIH 3T3 (hetero-
karyon assay) cells transfected to transiently express VHL-GFP. Cells were
then transferred to hypoxia in AP media. After nucleolar localization of
VHL-GFP, cells were fused and monitored by time-lapse microscopy.
Hoechst staining of DNA was used to identify donor and acceptor cells.
Arrows indicate the same position in the cell. (C) Unaltered MCF7 cells
were cocultured under standard conditions with MCF7 cells transfected to
transiently express B23-GFP. Cells were cultured in AP media, fused and
monitored as in B. Pseudocolored zooms of area indicated by dashed
square are shown.
Figure 6. FRAP analysis reveals that the redistribution of MDM2 from nu-
cleoplasm to nucleoli in response to perturbations in ribosomal biogenesis
alters general MDM2 dynamic state. MCF7 cells transfected to express
low levels of MDM2-GFP were cultured either under standard conditions
(A), or ribosomal stress (RS) (B) induced by ActD treatment (see Lohrum et
al., 2003 and Materials and methods). Cells were submitted to FRAP anal-
ysis as described for VHL in Fig. 3 by bleaching the indicated nucleoplas-
mic regions (white squares) or specific nucleoli (arrows) within specific nu-
clei (dashed circles). Pseudocolored zoom of area indicated by dashed
rectangle is shown in B. 
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Detention of ubiquitin ligases by the 
nucleolar architecture is a 
reversible process
 
Data presented so far suggest that the nucleolus captures the
highly mobile VHL for static detention upon the establishment of
cell type–specific extracellular pH threshold. We asked whether
this process is reversible and if VHL can be released from nucle-
oli to recover its highly mobile state. VHL rapidly reverts to a dif-
fuse nuclear cytoplasmic localization only after the reinstatement
of neutral pH conditions under hypoxia or normoxia conditions
(Fig. 1; Mekhail et al., 2004a). After reversion, fluorescence rap-
idly recovered after bleaching small nucleoplasmic regions (Fig.
7 G). These data indicate that the regulated inactivation of ligases
after targeting to the nucleolus relies on their transient conversion
to static participants of particular molecular networks.
 
Identification of a novel, discrete, 
pH-responsive nucleolar detention signal
 
Targeting of proteins to nucleoli is achieved by nucleolar lo-
calization sequence (NoLS) or nucleolar retention sequence
(NoRS). These sequences are relatively large and differ consid-
erably from nuclear import or export sequences, which are
comprised of only a few amino acid residues. Therefore, we
decided to identify the domain of the VBC/Cul-2 complex that
mediates [H
 
 
 
]-regulated nucleolar sequestration of VHL.
VHL is a component of the multi-protein ubiquitin ligase com-
plex that targets the transcription factor HIF for proteasomal
destruction. The complex is composed of at least VHL, elongin
B, elongin C, Cullin-2, and Rbx1 (VBC/Cul-2) (Fig. 8 A; Kae-
lin, 2002). The 
 
 
 
C157 deletion mutant of VHL, which is defec-
tive in E3 ligase complex formation (Fig. 8 A), retains the abil-
ity to target a GFP reporter to nucleoli in acidosis (Fig. 8 B,
first four panels) (Pause et al., 1997; Cockman et al., 2000;
Bonicalzi et al., 2001; Mekhail et al., 2004a). In contrast, Cullin-2
failed to target a GFP reporter to nucleoli of VHL-deficient cells
under the same conditions (Fig. 8 B). Although these data sug-
gest that complex formation is not required for nucleolar tar-
geting of VHL, immunoprecipitation analysis of acidotic cells
suggested that VHL can still assemble within the VBC/Cul-2
complex under acidic conditions (Fig. 8 C). Furthermore, when
Figure 7. Reversible static detention of VHL and MDM2 by
the nucleolar architecture. MCF7 cells were transfected to
express GFP-tagged MDM2 (A), B23 (B), or VHL (C–G) and
incubated under SD, AP, or RS conditions as indicated. A re-
gion representing about half of the nucleolar space (white
squares) of a single nucleolus was bleached and cells were
monitored by time-lapse fluorescence microscopy. Note the
absence of any changes in fluorescence for nucleolar VHL
and MDM2. Zoom of a single nucleolus is shown in C.
Changes in the shape of the border (dashed white outline set
by bleaching) of the protein concentration gradient from dif-
ferent time points as in C and D are overlayed in E. (F) Bor-
ders with changing (cytoplasm) or unaltered (nucleolus)
shapes (plotted on X and Y axes) were monitored for their
displacement away from their original position within the
field of vision. Only borders set within the nucleolar space
did not exhibit any movement. (G) After hypoxia-induced
acidification of AP media and confinement of VHL-GFP to the
nucleolus, NaOH was added to neutralize AP media (to pH
7.2) or cells were replenished with fresh SD media (pH 7.2)
to induce the reversion of VHL-GFP to the nucleo-cytoplasm
(also see Fig. 1). FRAP analyses in which small nucleoplas-
mic regions were bleached reveal that VHL-GFP resumes its
high mobility profile after a return to neutral pH conditions. 
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cotransfected with at least an equimolar amount of VHL, Cul-
lin-2 colocalized with VHL in the nucleoli of acidotic cells
(Fig. 8, D–F). Cullin-2 is also immobile in the nucleolus of
acidic cells, suggesting that VHL responds to changes in extra-
cellular pH and dictates the dynamic status of the assembled
VBC/Cul-2 E3 ligase complex (unpublished data). Together,
these data identify a novel role for the VHL tumor suppressor
in regulating the subcellular trafficking dynamics of the VBC/
Cul-2 ubiquitin ligase complex by targeting it to the nucleolus
in response to an increase in environmental H
 
 
 
 concentrations.
Mapping analyses of MDM2 and its associated proteins
have previously identified small aminopeptide sequences that
can target a GFP reporter protein to the nucleolus in response
to various physiological signals (Weber et al., 2000; Lohrum et
al., 2003). Deletion mutant analysis of VHL was therefore
conducted to identify minimal nucleolar detention sequences.
Figure 8. pH-responsive nucleolar detention signal (NoDS
H ) allows VHL to target the VBC/Cul-2 ubiquitin ligase complex for static detention in the nucleolus.
(A) Schematic representation of the VBC/Cul-2 complex.  C157 is a mutant of VHL that fails to assemble the complex. Positions of different amino acids
of VHL are indicated. (B) Complex formation is not required for nucleolar localization. VHL-deficient 786-0 cells were infected to express GFP-tagged VHL,
 C157, or Cullin-2 and transferred to hypoxia in AP media. Acidosis triggered the nucleolar relocation of VHL-GFP and  C157-GFP, but not of GFP-Cul-
lin-2. (C–F) VHL targets components of its ubiquitin ligase complex to the nucleolus. (C) VHL-deficient 786-0 cells were left uninfected or infected to express
flag-tagged VHL-GFP or GFP alone and incubated in hypoxia in SD or AP media. When  60% of the cells in AP conditions displayed  30% nucleolar ac-
cumulation of VHL-GFP, cells were lysed and submitted to anti-flag immunoprecipitation and silver staining. Acidosis did not cause any sudden disruption
of the VBC/Cul-2 complex. (D) VHL-deficient 786-0 cells cotransfected to transiently express VHL-BFP and GFP-Cullin-2 (1:1 ratio) were transferred to hyp-
oxia in SD or AP conditions. Cullin-2 colocalized with VHL to the nucleolus in acidosis (arrowheads). (E and F) VHL-deficient 786-0 cells were cotransfected
to transiently express VHL-BFP and GFP-Cullin-2 to varying ratios (indicated on panels and graph). VHL is the limiting factor in the nucleolar colocalization
(arrows) of VHL and Cullin-2. (G) VHL mapping analysis. MCF7 cells transfected to transiently express indicated GFP-tagged proteins were incubated in
AP media for 20 h in hypoxia. Schematic of VHL exons and derived amino acid domains are shown. Nucleolar localization was scored according to rep-
resentative images in (H). Amino acid residues 100–130 of the VHL protein were identified as the minimal domain to recapitulate the nucleolar localiza-
tion potential of the wild-type VHL tumor suppressor protein in acidosis. “a.d.” denotes acidic domain. (I) VHL(100–130) represents a surface pocket on
the VHL protein as revealed by molecular modeling (PyMOL). Each amino acid within that sequence is represented in a different color for better visual-
ization. MCF7 cells were transfected to transiently express VHL(100–130)-GFP at low (J) or high (K and L) levels and transferred to hypoxia under AP
conditions. Upon reaching a plateau for nucleolar targeting, cells were submitted to FLIP analysis in which a nucleoplasmic region (white square in K)
was repeatedly bleached. Insets in K show a pseudocolored zoom of a nucleolus (arrow). 
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Although  several regions within the 
 
 
 
-domain of VHL dis-
played relatively weak nucleolar localization activity in response
to acidosis, a domain encoding residues 100–130 recapitulated
the nucleolar targeting capability of wild-type VHL (Fig. 8,
G–I).  VHL(100–130) efficiently mediated the nucleolar de-
tention of a GFP reporter in acidosis as revealed by FLIP
experiments (Fig. 8 J). Neutralization of the media released
VHL(100–130) into the nucleoplasm where it resumed its dy-
namic mobility profile (unpublished data). In addition, similar
to the wild-type protein (Fig. 4, D and G), increasing the ex-
pression level of VHL(100–130) created a static nucleolar and
a dynamic nucleo-cytoplasmic pool (Fig. 8, K and L). Unlike
VHL(100–130), previously identified NLS and NES sequences
fail to respond to increases in extracellular hydrogen ion con-
centrations (Fig. 9), highlighting the functional specificity of
the herein identified domain. These findings identify a novel
and discrete protein domain as a new type of protein localiza-
tion sequence that we now refer to as [H
 
 
 
]-responsive nucle-
olar detention signal (NoDS
 
H
 
 
 
).
 
Discussion
 
We provide evidence that the nucleolar architecture serves as a
scaffold to convert highly mobile ubiquitin ligases to static par-
ticipants of their molecular networks in response to physiologi-
cal cues. This has various implications for our understanding of
the role of nuclear compartments in regulating the output of dy-
namic molecular networks. Unlike certain core histones, which
ensure chromatin stability by adopting a constitutive profile of
relative immobility (Abney et al., 1997; Kimura and Cook,
2001), most proteins, including heterochromatin protein-1
(Cheutin et al., 2003; Festenstein et al., 2003; Maison and Al-
mouzni, 2004), follow a stochastic model of high molecular
mobility to ensure efficient functional interactions. We propose
a model by which dynamic molecular networks, such as the
ubiquitylation system, are built on complex interactions be-
tween mobile and relatively static participants. According to
this model, modulation of these interactions through regulation
of the dynamic state of the participants alters the output of the
network. It is known that the interaction of the VBC/Cul-2 and
MDM2 ubiquitin ligases with the functional nuclear pore archi-
tecture is required for nuclear export and subsequent degrada-
tion of their substrates (Fig. 10 A) (Momand et al., 1992;
Oliner et al., 1993; Freedman and Levine, 1998; Roth et al.,
1998; Lee et al., 1999; Groulx and Lee, 2002). Although con-
stituents of the nuclear pore can move between subcellular
compartments, functional pore architecture is confined to the
nuclear envelope and persists for long periods of time within
well-defined spatial regions (Rabut et al., 2004). Therefore,
eliminating the physical interaction between an immobile and a
mobile participant only requires the immobilization of the dy-
namic participant at a different spatial coordinate. In the herein
described system, key interactions are abolished after static de-
Figure 9. Characteristics of the NoDS
H  sequence. (A) Shown is a sche-
matic representation of the VBC/Cul-2 complex. The NoDS
H  of VHL is
highlighted in red and its constituent amino acids (residues 100–130 of
VHL, inclusively) are indicated. (B) MCF7 cells were transiently transfected
to express GFP-tagged NES, NLS, NoDS
H  or GFP alone. Cells were incu-
bated in hypoxia under AP conditions with maximal acidifications of pH
6.9 or 6.3.
Figure 10. Regulation of ubiquitylation networks by the nucleolus. (A)
Ubiquitin ligases follow a stochastic model of molecular mobility to ensure
functional interactions such as those with the functional nuclear pore archi-
tecture at the nuclear envelope. (B) Complete static detention of ligases
within the nucleolar space abolishes these required molecular interactions.
(C) Detention of a fraction of the protein population results in a static nu-
cleolar pool while a second pool sustains dynamic functions in the nucleo-
plasm or cytoplasm. (D) Dynamic change in the steady-state distribution of
a protein from mainly nucleo-cytoplasmic to mainly nucleolar allows the
protein to assume dynamic functions in the nucleolus and other cellular
compartments. 
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tention of the ubiquitin ligases within the nucleolar space, a
phenomenon that alters network output (i.e., degradation of
substrates) (Fig. 10 B) as previously shown by work from our
and other groups (Tao and Levine, 1999; Weber et al., 1999;
Lohrum et al., 2003; Mekhail et al., 2004a). These data suggest
that static nucleolar detention selectively abolishes ubiquitin li-
gase functions requiring interactions with immobile constitu-
ents of the ubiquitylation networks. Whether VHL or MDM2
retain other functions when sequestered in nucleoli, or assume
new roles, remains unknown.
The redistribution of dynamic nucleo-cytoplasmic pro-
teins to the nucleolus can be classified in three main categories.
First, complete nucleolar detention results in the conversion of
a mobile protein to a static participant of its molecular network
(Fig. 10 B). Second, detention of a fraction of the protein popu-
lation results in a static nucleolar pool while a second pool sus-
tains dynamic functions in the nucleoplasm or cytoplasm (Fig.
10 C). Third, dynamic change in the steady-state distribution of
a protein from mainly nucleo-cytoplasmic to mainly nucleolar
allows the protein to assume dynamic functions in the nucleo-
lus and other cellular compartments (Fig. 10 D). It is possible
that a single protein can be targeted to the nucleolus through
different mechanisms (Fig. 10, B–D) to custom-tailor specific
dynamic profiles in response to different signals. Alternatively,
ubiquitin ligases can be regulated through nonnucleolar mecha-
nisms, such as inactivating post-translational modifications, to
control ubiquitylation without altering general dynamic proper-
ties of the ligase in the cell.
Specific aminopeptide sequences, such as NLS, NES, and
NoLS, target proteins to various cellular regions. Mapping anal-
ysis of the VHL tumor suppressor protein identified a new type
of protein localization sequence, NoDS
 
H
 
 
 
, which is activated
after a decrease in extracellular pH to target proteins for static
detention in the nucleolus. NoDS
 
H
 
 
 
 is inactivated after a return
to neutral pH conditions, causing rapid release of detained pro-
teins into the nucleoplasm. The NoDS
 
H
 
 
 
 is one of the first dis-
crete domains that have been identified to target proteins to the
nucleolus and differs considerably from other NoLS and NoRS
signals in its size and mode of regulation. The NoDS
 
H
 
 
 
 is char-
acterized by the presence of several arginine residues (Fig. 9 A)
that are known to be involved in targeting proteins to the nucle-
olus. It is possible that these residues are involved in pH-regu-
lated targeting of VHL to nucleoli, whereas other residues play
a role in static detention. Further investigation will be required
to decipher the mechanisms by which extracellular hydrogen
ions activate the NoDS
 
H
 
 
 
 of VHL. It will also be important to
screen proteins for similar sequences, as they could play vital
roles in altering general protein dynamics and metabolism in re-
sponse to changes in extracellular hydrogen ion concentration.
Consistent with the hypothesis that nucleolar sequestration may
be a general phenomenon is the recent report that the nucleolus
can capture and release several proteins in response to different
cellular cues (Andersen et al., 2005).
In conclusion, our findings highlight the role of the nucle-
olus in regulating protein dynamics, localization, and function.
We propose a model by which, via reversible interactions with
the  nucleolar architecture, ubiquitin ligases alternate between
dynamic and static states to alter the output of their complex mo-
lecular networks. There is ample evidence that proteins are
highly mobile molecules that function through stochastic interac-
tions with binding partners. This paper provides evidence that
cells have evolved a mechanism to regulate molecular networks
by switching proteins between mobile and immobile states and
highlight the role of the nucleolus in sequestering molecules.
 
Materials and methods
 
Cells and materials
 
C2C12 and PC12 cells from the American Type Culture Collection (Ma-
nassas, VA) were differentiated by lowering the serum concentration from
5 to 0.5% or by addition of NGF (50 ng ml
 
 
 
1
 
), respectively, before infec-
tion with adenoviruses. 786-0 (VHL-defective), U87MG, HOP62, MCF7,
MDA-MB-231, SF295, and H9C2 cells were also obtained from the Amer-
ican Type Culture Collection. VHL-negative 117 cells were a gift from
James Gnarra (Louisiana State University, Baton Rouge, LA). 786-0 (Lee et
al., 1999), 117 (Mekhail et al., 2004a), or MCF7 cells stably expressing
VHL–GFP were generated as described previously (Lee et al., 1999).
Where indicated, fluorescein diacetate (5 
 
 
 
M) and propidium iodide
(2 
 
 
 
M) (Sigma-Aldrich) were added to cells 20 min from endpoint.
 
Cell culture
 
Normoxic cells were incubated at 37
 
 
 
C under a 5% CO
 
2
 
 environment.
Hypoxia was achieved by incubation in a hypoxic chamber at 37
 
 
 
C un-
der a 1% O
 
2
 
, 5% CO
 
2
 
, and N
 
2
 
-balanced atmosphere. Acidosis (VHL)
(Mekhail et al., 2004a) and ribosomal perturbation (MDM2) (Lohrum et
al., 2003) experiments were conducted as previously described. For SD
or AP conditions, buffer-free medium (DME; Invitrogen) was freshly pre-
pared and supplemented with 5% (vol/vol) FBS and 1% (vol/vol) penicil-
lin-streptomycin. NaHCO
 
3
 
 (44 mM) was added and the pH was adjusted
to 7.2 (SD) or 5.4–7.2 (AP) with HCl. Air was bubbled into both media at
22
 
 
 
C, which stabilizes the pH at 7.2. AP media slowly reverted to its orig-
inal pH (5.4–7.2) under hypoxia, whereas the SD medium remained at
pH 7.2. MDM2 ribosomal stress (RS) conditions were induced in SD me-
dia by addition of 15 nM ActD (Calbiochem) for the last 2 h of a 6-h
treatment with 20 
 
 
 
M MG132 (Calbiochem) (Lohrum et al., 2003).
Transfected or adenovirus-infected cells were grown for 24 h under stan-
dard conditions before any treatment.
 
Plasmids and adenoviruses
 
VHL and its variants and mutants were cloned between an NH
 
2
 
-terminal
Flag-tag and a COOH-terminal GFP-tag and into pcDNA3.1, as previ-
ously described (Bonicalzi et al., 2001; Groulx and Lee, 2002). Adeno-
viruses were produced using the Cre-lox recombination system. Cullin-2
construct is previously described (Groulx et al., 2000). We sincerely
thank Tom Misteli (National Cancer Institute, Bethesda, MD) for providing
UBF1-GFP and FIB-GFP constructs; Mark Olson (University of Mississippi
Medical Center, Jackson, MS) for B23-GFP construct; Gang Pei (Shangai
Institute of Biological Sciences, Shangai, China) for MDM2-GFP; and Uri
Alon (Weizmann Institute of Science, Rehovot, Israel) and Galit Lahav
(Harvard Medical School, Boston, MA) for MDM2-YFP. Transient transfec-
tions were conducted with Effectene transfection reagent (QIAGEN).
 
Immunoprecipitation
 
Cells lysis and immunoprecipitations were conducted as previously de-
scribed (Groulx and Lee, 2002). In brief, M2 beads were added to total
cell lysates containing 1 mg of protein. After 1 h tumbling at 4
 
 
 
C, beads
were washed several times, eluted with flag peptides. Eluates were boiled
before undergoing Western blotting. Gels were silver stained according to
manufacturer’s protocol (Bio-Rad Laboratories).
 
Immunoblotting
 
Samples were separated on denaturing polyacrylamide gels containing
SDS and transferred to methanol-activated polyvinylidene difluoride mem-
brane (NEN Life Science Products). Membranes were blocked in skimmed
milk before incubation with antibodies to VHL (BD Biosciences) (Kibel et
al., 1995; Corless et al., 1997; Mekhail et al., 2004a) or HIF-2
 
 
 
 (Novus)
(Mekhail et al., 2004a). After washing with a 0.2% Tween-PBS solution,
membranes were blotted with a secondary antibody conjugated to HRP
(Jackson ImmunoResearch Laboratories) and detected by Western Light-
ning Chemiluminescence Reagent Plus (PerkinElmer). 
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Immunofluorescence microscopy
 
Cells were seeded onto coverslips and fixed with prechilled (to 
 
 
 
20
 
 
 
C)
methanol for 10 min followed by acetone for 1 min. An anti-B23 mAb
(Sigma-Aldrich) was used. Cells were incubated for 1 h with a primary an-
tibody solution containing 10% FBS and 1% Triton X-100 (vol/vol). Cells
were washed several times in PBS before 1 h incubation with a secondary
Texas red–labeled antibody (Jackson ImmunoResearch Laboratories). Im-
ages of fixed cells were captured with a microscope (Axioskop 2 MOT
PLUS; Carl Zeiss MicroImaging, Inc.) using a digital charged-coupled de-
vice camera (Qimaging). Compartmental fluorescence was measured as
described previously (Lee et al., 1999; Mekhail et al., 2004a).
 
Photobleaching and microscopy
 
Cells cultured on 40-mm-diameter glass coverslips were visualized on a
confocal microscope (MRC 1024; Bio-Rad Laboratories) in an FCS2 envi-
ronmental chamber (Bioptechs) maintained at 37
 
 
 
C or, where indicated,
directly into 35-mm dishes with coverslip bottoms. A 60
 
 
 
 plan Apo oil
immersion lens with a 1.4 NA was used for bleaching and imaging. Indi-
cated areas were exposed to five rapid pulses of a 488-nm argon laser
at 100% power and image acquisition was conducted at 1% of full laser
power. For FRAP experiments, images were collected at 1- or 5-s inter-
vals. Recovery of the fluorescent signal within a bleached region was cal-
culated as described by Phair and Misteli (2000) following I
 
rel
 
 
 
 
 
 (I
 
(t)
 
/I
 
(0)
 
)
* (T
 
(0)
 
/T
 
(t)
 
), where T
 
(t)
 
 is the total cellular intensity at time t, T
 
(0)
 
 is total cel-
lular intensity before bleach, I
 
(0)
 
 is the intensity in the bleached area be-
fore bleach, and I
 
(t)
 
 is the intensity in the previously bleached area at time
t. For iFRAP nuclear export experiments the whole cytoplasm was
bleached and cells were monitored in 30-s intervals. Relative loss of total
fluorescence in the unbleached nucleus was calculated as Irel   (I(t)/I(0)) *
(N(0)/N(t)), where I(t) is the average intensity of the unbleached nucleus at
time point t, I(0) is the average prebleach intensity of the nucleus of inter-
est, and N(0) and N(t) are the average total cellular fluorescence intensi-
ties of a neighboring cell in the same field of vision at prebleach or at
time point t, respectively. For FLIP experiments, cells were repeatedly
bleached and imaged at 5-s intervals and fluorescence loss in un-
bleached areas was calculated similar to iFRAP calculations to account
for any losses in fluorescence by normalizing the fluorescence in the cell
of interest to that of a neighboring cell. Where indicated, cycloheximide
(20  g ml
 1) was added 1 h from endpoint. For all bleaching experi-
ments, at least 10 datasets were analyzed for each result. Average pixel
intensities were normalized for background fluorescence. Images of liv-
ing cells from experiments that do not implicate bleaching were captured
with a microscope (Axiovert S100TV; Carl Zeiss MicroImaging, Inc.)
equipped with a 40 /1.2 C-Apochromat water immersion objective us-
ing a digital charged-coupled device camera (Empix). Pseudocoloring for
bleaching and fusion experiments was achieved by applying the gradi-
ent map function of Photoshop (Adobe) to a montage of picture frames
prepared with Image J (National Institutes of Health, Bethesda, MD) soft-
ware. Other software packages used to capture images, analyze the
data, and generate graphs include Northern Eclipse (Empix), Excel (Mi-
crosoft), and FreeHand (Macromedia).
Polykaryon assay
For VHL-GFP relocation to the nucleolus in homokaryon fusion assays,
cells were transfected according to manufacturer’s protocol to express flu-
orescent-labeled proteins and incubated under in standard conditions for
24 h (Lee et al., 1999). Usually between 40 and 60% of cells presented
strong fluorescence. Cells were washed twice with warm PBS and fused
for 2 min by addition of a warm 50% solution of PEG in PBS (Sigma-
Aldrich). PEG was removed thoroughly by four washes with warm PBS
and cells were incubated for 30 min under standard conditions. Cells were
then replenished with AP media (see Cell culture) and transferred to hyp-
oxia. After acidification, cells were monitored for the distribution of VHL-
GFP in polykaryonic cells. For VHL-GFP and B23-GFP dynamic trafficking
assays (Fig. 5, B and C), cells were transfected to express GFP-tagged
proteins or left unaltered. The cells were then mixed at a 1:10 ratio,
plated in 35-mm-diameter culture dish with a girded coverslip as its base,
and exposed to hypoxia in AP media. After acidification and redistribu-
tion of VHL-GFP to nucleoli, cells were fused by PEG treatment as de-
scribed above. This process yielded a significant number of polykaryonic
cells where the fluorescence observed in the cell is only associated with
nucleoli of only one or two nuclei, whereas other nuclei within the same
polykaryonic cell displayed no fluorescence. Hypoxic cells were then rap-
idly washed twice with nonbuffered acidic media (pH 6.0–6.5), replen-
ished with their original acidified AP media, and cells were monitored by
fluorescence microscopy.
Online supplemental material
Fig. S1 shows characteristics of cells and VHL subcellular trafficking in
hypoxia-acidosis. Fig. S2 shows that both forms of VHL relocate to the
nucleolus in response to the same pH threshold in cells stably expressing
the GFP-tagged proteins. Fig. S3 shows a comparison of nuclear export
of VHL under neutral and acidic conditions using iFRAP. Fig. S4 shows
how FLIP analysis indicates that the redistribution of MDM2 from nucleo-
plasm to nucleoli alters general MDM2 dynamic state. Online sup-
plemental material available at http://www.jcb.org/cgi/content/full/
jcb.200506030/DC1.
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